Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients

被引:153
作者
Herbeuval, JP
Nilsson, J
Boasso, A
Hardy, AW
Kruhlak, MJ
Anderson, SA
Dolan, MJ
Dy, M
Andersson, J
Shearer, GM
机构
[1] Natl Canc Inst, NIH, Expt Immunol Branch, Bethesda, MD 20092 USA
[2] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Ctr Infect Med, SE-17177 Stockholm, Sweden
[3] Def Inst Med Operat, Infect Dis Serv, Wilford Hall Med Ctr, Lackland AFB,, Brooks AFB, TX 78235 USA
[4] Def Inst Med Operat, Tri Serv AIDS Clin Consortium, Brooks AFB, TX 78235 USA
[5] Univ Paris 05, Fac Med, UMR 8147, CNRS, F-75270 Paris 06, France
关键词
pDC; IRF-7; MyD88; AT-2; HIV-1;
D O I
10.1073/pnas.0600363103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Loss of CD4(+) T cells, the hallmark of HIV pathogenesis, was suggested to be partly due to apoptosis. We recently reported that IFN-alpha produced by HIV-1-activated plasmacytoid dendritic cells (pDCs) contributes to CD4(+) T cell apoptosis by the TNF-related apoptosis-inducing ligand (TRAIL)/death receptor (DR)5 pathway. Here, we show that HIV-1-induced intracellular expression of IFN-alpha in pDCs is coupled to increased expression of IFN regulatory factor 7 and MyD88 by pDCs in vivo and in vitro. Expression of IFN-a was increased in lymphoid tonsillar tissue (LT) of patients with progressive (HIVprog) compared with nonprogressive (HIVNP) HIV-1 disease and to uninfected controls. LT from HIVprog exhibited higher TRAIL and DR5 mRNA levels than LT from HIVNP or controls. TRAIL mRNA levels in LT correlated with plasma viral load. We show that HIV-1 induces IFN-alpha and the TRAIL/DR5 apoptotic pathway in LT, suggesting a role for these cytokines in HIV-1 immunopathogenesis.
引用
收藏
页码:7000 / 7005
页数:6
相关论文
共 39 条
[1]   Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection [J].
Andersson, J ;
Kinloch, S ;
Sönnerborg, A ;
Nilsson, J ;
Fehniger, TE ;
Spetz, AL ;
Behbahani, H ;
Goh, LE ;
McDade, H ;
Gazzard, B ;
Stellbrink, H ;
Cooper, D ;
Perrin, L .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09) :1355-1358
[2]   In vivo analysis of Fas/FasL interactions in HIV-infected patients [J].
Badley, AD ;
Dockrell, DH ;
Algeciras, A ;
Ziesmer, S ;
Landay, A ;
Lederman, MM ;
Connick, E ;
Kessler, H ;
Kuritzkes, D ;
Lynch, DH ;
Roche, P ;
Yagita, H ;
Paya, CV .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :79-87
[3]  
Beignon AS, 2005, J CLIN INVEST
[4]   CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract [J].
Brenchley, JM ;
Schacker, TW ;
Ruff, LE ;
Price, DA ;
Taylor, JH ;
Beilman, GJ ;
Nguyen, PL ;
Khoruts, A ;
Larson, M ;
Haase, AT ;
Douek, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (06) :749-759
[5]   Plasmacytoid dendritic cells in immunity [J].
Colonna, M ;
Trinchieri, G ;
Liu, YJ .
NATURE IMMUNOLOGY, 2004, 5 (12) :1219-1226
[6]   Viral infection switches non-plasmacytoid dendritic cells into high interferon producers [J].
Diebold, SS ;
Montoya, M ;
Unger, H ;
Alexopoulou, L ;
Roy, P ;
Haswell, LE ;
Al-Shamkhani, A ;
Flavell, R ;
Borrow, P ;
Sousa, CRE .
NATURE, 2003, 424 (6946) :324-328
[7]   A dual role of IFN-α in the balance between proliferation and death of human CD4+ T lymphocytes during primary response [J].
Dondi, E ;
Roué, G ;
Yuste, VJ ;
Susin, SA ;
Pellegrini, S .
JOURNAL OF IMMUNOLOGY, 2004, 173 (06) :3740-3747
[8]   The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy [J].
Dyrhol-Riise, AM ;
Stent, G ;
Rosok, BI ;
Voltersvik, P ;
Olofsson, J ;
Åsjö, B .
CLINICAL IMMUNOLOGY, 2001, 101 (02) :169-179
[9]   T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy [J].
Dyrhol-Riise, AM ;
Ohlsson, M ;
Skarstein, K ;
Nygaard, SJT ;
Olofsson, J ;
Jonsson, R ;
Åsjö, B .
CLINICAL IMMUNOLOGY, 2001, 101 (02) :180-191
[10]   Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells [J].
Fonteneau, JF ;
Larsson, M ;
Beignon, AS ;
McKenna, K ;
Dasilva, I ;
Amara, A ;
Li, YJ ;
Lifson, JD ;
Littman, DR ;
Bhardwaj, N .
JOURNAL OF VIROLOGY, 2004, 78 (10) :5223-5232